page, the one linked to by dangertim:
https://med.umn.edu/news-events/u-m-medical-school-receives-15m-launch-nation%E2%80%99s-first-ivermectin-covid-19-treatment-clinical-trial
The study is simple — patients are randomized to receive 14 days’ worth of either one of the three drugs individually, a placebo or a combination of metformin and fluvoxamine or fluvoxamine and ivermectin to take twice per day and track their symptoms. After 14 days, volunteers complete a survey.